During the past decade, CeSI (Centro di Scienze dell'invecchiamento) - conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CeSI (Centro di Scienze dell'invecchiamento) -" are "Alzheimer Disease" (2 trials). Many other conditions were trialed in "CeSI (Centro di Scienze dell'invecchiamento) -" in a lesser frequency.

Most popular intervention types in "CeSI (Centro di Scienze dell'invecchiamento) -" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "bapineuzumab" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "CeSI (Centro di Scienze dell'invecchiamento) -" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CeSI (Centro di Scienze dell'invecchiamento) -". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in CeSI (Centro di Scienze dell'invecchiamento) -, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CeSI (Centro di Scienze dell'invecchiamento) -, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".